think weak share partli due mismodel share count
street overlook mix shift toward specialti model reflect
beyond management comment regard benefit vertic integr
appear well receiv although truth benefit recent vertic
definit proven least yet
oper miss quarter like due mismodel street
think weak share today least partli due mismodel
share count street led miss oper metric adj
gross margin adj oper incom quarter despit beat adj ep
lower expect share count like attribut share repurchas later
lead dramat lower share count addit believ
mani like properli account mix shift toward specialti script
result alliancerx led bp headwind gross margin retail usa
segment look forward toward next quarter think investor mind
continu headwind alliancerx well onboard fep contract
start januari headwind alliancerx anniversari
headwind onboard fep anniversari
investor focus recent trend vertic integr
view today declin share like also attribut management comment
regard philosophi benefit vertic integr necessarili
achiev ownership achiev effect close
partnership collabor contrari current market trend number
compani announc merger acquisit consolid vertic
investor appear propon reflect share perform instead
management note still great deal done optim current asset
current halfway transform process entail upgrad
exist busi pharmaci retail defens recent trend vertic
integr definit proven like sometim conclus
determin made howev could perceiv may fall behind
peer given market posit view vertic integr could weigh
share near term
updat estim price target
rais adj ep estim lower adj ep
estim also lower price target base
revis dcf analysi impli share trade adj ep
estim current multipl
pleas see page report import disclosur
posit outlook base belief under-valued
fundament basi think investor sentiment overli pessimist like due
potenti threat howev view best posit amongst
drug retail navig threat management appear forward think
evidenc strateg partnership furthermor beauti differenti program
yield result led gross margin expans front-end also
continu launch self-manufactur health beauti brand beyond soap
 glori help expand margin lastli also see option
potenti upsid medium long-term well addit partnership given management
penchant deal drive sharehold valu
 announc regard
 y/i top-lin growth driven
growth part acquisit
alliancerx includ fep contract
 margin pressur continu part
specialti new partnership
 share repo
 y/i top-lin growth mid- high-
 y/i top-lin growth high-singl
 lower expect margin pressur
 higher expect margin pressur
 share repo greater
 better expect f-e margin
 wors expect f-e margin
walgreen oper largest drugstor chain compani sell product
servic retail drugstor mail telephon on-line
channel within store walgreen sell prescript non-prescript drug
well gener merchandis includ household item conveni fresh food
person care beauti care photofinish candi primarili within retail locat
walgreen oper take clinic walgreen also oper specialti infus
respiratori servic mail servic
million except per share data
cowen compani
model assumptionstermin growth tax depreci chang work terminal- capit valuefre pv npv free npv futur excess valu total number valu per year end august cowen
million except per share data
cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn adjust equiti earn abc- adjust oper adjust oper expens pre-tax pre-tax tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper year end august cowen
million except per-shar data
cowen compani
fifo cost fifo gross fifo gross chang lifo lifo gross lifo gross equiti earn ab- adjust equiti earn adjust oper adjust oper expens pre-tax pre-tax tax incom tax tax earn equiti method net earn non-controlling adjust net total net averag dilut adjust chang gross gross oper cowen
million
cowen compani
asset cash account receiv current current properti intang non-curr total current liabil short-term trade account accru expens incom current long-term defer incom non-curr stockhold equiti common paid-in employe stock loan retain accumul comprehens treasuri non-controlling total stockhold total liabil stockhold short-term liquid ratio current sale purchas acct ratio inventori structur long-term solvenc ratio total debt total interest ratio return invest capit averag total asset averag stockhold equiti year end august cowen
million
cowen compani
income/ loss flow oper activ depreci gain previous held equiti interest- share base compens unreal gain fair valu adjustments- defer incom invest impair chang oper asset liabil receiv current non-curr assets- account accru expens incom non-curr net cash oper acquisit properti acquisit issuanc common purchas treasuri dividend proceeds/ purchas secur proceeds/ repay debt net increase/ decreas cash equival begin cash equival end cowen summari oper capit owner financ non-recur exclud non-recur itemsfor year end august cowen
million
cowen compani
flow oper activ net adjust reconcil net earn net cash depreci loss allianc boot call option- sale business- defer incom stock compens incom tax save employe stock plans- chang oper asset liabil account receiv current trade account accru expens incom non-curr asset net cash provid oper flow invest activitiesaddit properti proce sale leaseback transactions- purchas short-term invest held maturity- proce short-term invest held maturity- purchas short-term invest avail sale- proce sale short-term invest avail sale- return invest restrict proce sale busi intang asset acquisit net cash payment proce sale invest invest allianc net cash use invest flow financ activitiesnet payment short-term borrowings- payment long-term debt- proce financ leases- issuanc long-term stock proce relat employe stock dividend net cash provid use financ effect exchang rate chang cash cash equivalents- chang equivalentsnet decreas cash cash cash equival begin cash equival end year end august cowen
use five-year discount cash flow analysi primari valuat method
deriv price target gener assum discount rate may appli
appropri adjust depend compani and/or industri specif factor also
assum termin growth rate depend long-term view specif
sub-industri coverag note discount rate assumpt could view
conserv rel actual weight averag cost capit view
assumpt reason long run lower discount rate assumpt
increas termin growth rate assumpt would lead higher estim valu
per share secondari measur look forward price-to-earnings multipl ev/sal ratio
impli dcf analysi compar histor averag
see number risk associ drug retail space industri highli
competit retail drugstor chain independ pharmaci mail-ord provid
well retail includ groceri store mass merchant warehous club on-line
store compet space could pressur front-end sale margin
current wave drug patent expir posit impact profit
deriv gener expect taper significantli next sever year
specialti provid signific tailwind part believ
could concern around sustain high growth area
believ impact ppaca expect increas volum could subdu
depend implement execut
number company-specif risk associ pt includ
underwhelm perform proprietari health beauti brand eg
botan soap glori liz earl deceler pace synergi captur cost
reduct wors expect reimburs pressur unfavor exchang
rate dollar versu british pound sterl
author research report herebi certifi view express research report accur reflect person view subject
secur issuer ii part compens relat directli indirectli specif recommend view express report
cowen compani llc affili make market stock secur
cowen compani llc compens research analyst activ servic intend benefit firm investor client individu compens determin research
analyst includ author report base varieti factor includ overal profit firm total revenu deriv sourc includ
revenu invest bank sale trade princip trade revenu cowen compani llc compens research analyst base specif invest
bank transact specif sale trade princip trade revenu
research report simultan avail client client websit research report client research report dissemin e-mail
made avail third-parti aggreg cowen compani llc respons redistribut research third parti aggreg select research report
avail print form addit electron form publish research report obtain firm client websit http //cowenlibrari bluematrix com/client/
inform opinion estim forecast date report subject chang without prior notif seek updat research appropri
variou regul may prevent us research report publish irregular interv appropri analyst judgement
inform subject secur may obtain offic research report publish sole inform purpos constru offer
sell solicit offer buy secur state offer solicit would illeg disclosur relat cowen compani llc
inform herein base sourc believ reliabl guarante us purport complet statement summari avail data
opinion express herein statement judgment date subject chang without notic opinion recommend herein take
account individu client circumst object need intend recommend invest strategi recipi report must make
independ decis regard secur subject research report case secur financi instrument may difficult valu sell reliabl
inform valu risk relat secur financi instrument may difficult obtain extent report discuss legal proceed issu
prepar express intend express legal conclus opinion advic salespeopl trader profession may provid oral written
market commentari trade strategi client reflect opinion contrari opinion express research princip trade area invest
busi may make invest decis inconsist recommend view express research cowen compani llc maintain physic electron
procedur inform barrier address flow inform among depart within cowen compani llc order prevent avoid conflict
interest respect analyst recommend
import disclosur regard compani subject research report pleas contact complianc depart cowen compani llc lexington
